This inventor holds 2 USPTO granted patents. Top assignee: Centre Europeen De Bioprospective-Ceb. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saint-Yrieix-la-Perche, FR (2001)
- La Grande Motte, FR (2001)
Company Filing History:
Years Active: 2001
Title: Pierre Germain: Innovator in Retinoid-Type Derivatives
Introduction
Pierre Germain is a notable inventor based in Saint-Yrieix-la-Perche, France. He has made significant contributions to the field of pharmaceutical and cosmetic compositions through his innovative work on retinoid-type derivatives. With a total of two patents to his name, Germain's inventions are paving the way for advancements in various applications.
Latest Patents
Germain's latest patents include "Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions." This invention focuses on novel aromatic polycyclic retinoid-type derivatives of a specific general formula. Additionally, he has developed "Aromatic tetracyclic compounds of the retinoid type, method for preparing and use," which concerns aromatic tetracyclic compounds of the retinoid type and their preparation methods, along with pharmaceutical compositions containing these compounds.
Career Highlights
Pierre Germain is associated with the Centre Européen de Bioprospective (CEB), where he continues to explore innovative solutions in bioprospecting. His work is characterized by a commitment to enhancing the efficacy of pharmaceutical and cosmetic products through scientific research and development.
Collaborations
Germain has collaborated with notable colleagues such as Bertrand Leblond and Alain-René Schoofs. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
In summary, Pierre Germain is a distinguished inventor whose work on retinoid-type derivatives has significant implications for the pharmaceutical and cosmetic industries. His innovative patents and collaborations highlight his dedication to advancing scientific knowledge and practical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile